EA199800177A1 - Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом - Google Patents

Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом

Info

Publication number
EA199800177A1
EA199800177A1 EA199800177A EA199800177A EA199800177A1 EA 199800177 A1 EA199800177 A1 EA 199800177A1 EA 199800177 A EA199800177 A EA 199800177A EA 199800177 A EA199800177 A EA 199800177A EA 199800177 A1 EA199800177 A1 EA 199800177A1
Authority
EA
Eurasian Patent Office
Prior art keywords
patient
diabetes mellitus
reducing
dependent diabetes
noninsulin
Prior art date
Application number
EA199800177A
Other languages
English (en)
Inventor
Рэндал В. Уиткомб
Original Assignee
Варнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Варнер-Ламберт Компани filed Critical Варнер-Ламберт Компани
Publication of EA199800177A1 publication Critical patent/EA199800177A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение обеспечивает способ снижения экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом, состоящий в том, что пациенту вводят терапевтически эффективное количество производного тиазолидиона и/или родственных соединений.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800177A 1995-08-10 1996-07-29 Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом EA199800177A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US209895P 1995-08-10 1995-08-10
PCT/US1996/012430 WO1997005875A2 (en) 1995-08-10 1996-07-29 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
EA199800177A1 true EA199800177A1 (ru) 1998-10-29

Family

ID=21699238

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800177A EA199800177A1 (ru) 1995-08-10 1996-07-29 Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом

Country Status (15)

Country Link
EP (1) EP0851757A2 (ru)
JP (1) JPH11510508A (ru)
KR (1) KR19990036290A (ru)
CN (1) CN1192683A (ru)
AU (1) AU724989B2 (ru)
BG (1) BG102235A (ru)
CA (1) CA2221241A1 (ru)
CZ (1) CZ32998A3 (ru)
EA (1) EA199800177A1 (ru)
HU (1) HUP9802543A2 (ru)
IL (1) IL122191A0 (ru)
NO (1) NO980556D0 (ru)
NZ (1) NZ313874A (ru)
SK (1) SK16498A3 (ru)
WO (1) WO1997005875A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
GB2335597A (en) * 1998-03-27 1999-09-29 Glaxo Group Ltd Stereoisomers of Troglitazone in the Treatment of Diabetes
FR2838968A1 (fr) * 2002-04-30 2003-10-31 Lipha Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
NO980556L (no) 1998-02-09
AU6641196A (en) 1997-03-05
BG102235A (en) 1998-09-30
IL122191A0 (en) 1998-04-05
JPH11510508A (ja) 1999-09-14
NO980556D0 (no) 1998-02-09
SK16498A3 (en) 1999-03-12
CN1192683A (zh) 1998-09-09
EP0851757A2 (en) 1998-07-08
WO1997005875A2 (en) 1997-02-20
CA2221241A1 (en) 1997-02-20
KR19990036290A (ko) 1999-05-25
CZ32998A3 (cs) 1998-10-14
AU724989B2 (en) 2000-10-05
HUP9802543A2 (hu) 1999-07-28
NZ313874A (en) 2000-09-29
WO1997005875A3 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
EA200000041A1 (ru) Способ лечения диабета тиазолидиндионом и метформином
ES2187659T3 (es) Tratamiento de la diabetes mellitus de tipo ii con agonistas de amilina.
FI842915A0 (fi) Farmaceutiskt medel foer behandling av diabetes.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
HUP9800523A2 (hu) Inzulinszármazékok
RO117913B1 (ro) Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament
CA2043033A1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine
IT1279684B1 (it) Siringa per iniezioni ipodermiche.
CA2047903A1 (en) Calcitonin-containing emulsion for nasal administration
EA200000139A1 (ru) Лечение диабета тиазолидиндионом, средством, стимулирующим секрецию инсулина, и дигуанидом
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
EA200000141A1 (ru) Способ лечения диабета тиазолидиндионом и сульфонилмочевиной
ES2181923T3 (es) 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
BG104062A (en) Treatment of diabetes with thiazolidindion, stimulant of insulin secretion and alpha-glucosidase inhibitor
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
EA200000039A1 (ru) Лечение диабета тиазолидиндионом и сульфонилмочевиной
MX9709958A (es) Un metodo para reducir la cantidad de insulina exogena administrada a un paciente que tenga diabetes melitus dependiente de insulina.
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.